ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 351075 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 351075; 2) Community: the network communities that were significantly associated with the response to NSC 351075; 3) Molecule: the relationships between components within communities and NSC 351075; 4) MDR: the compounds that were significantly associated with the NSC 351075.

NSC Compound Enrichment Correlation
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.00248668807445191 -0.43089515
NSC 622297 Null 0.00248668807445191 0.53108523
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.00248668807445191 0.59722657
NSC 625544 Null 0.00248668807445191 0.53502906
NSC 625731 Null 0.00248668807445191 0.50157688
NSC 626162 Discorhabdin C . TFA 0.00248668807445191 0.61949636
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00248668807445191 0.5372611
NSC 644651 Null 0.00248668807445191 0.60715571
NSC 666787 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate 0.00248668807445191 0.40799464
NSC 684901 Null 0.00248668807445191 0.45332354
Total:122  Current:14    [First] [Prev] [Next] [Last]